Inactive Instrument
Company American Renal Associates Holdings, Inc.
Stocks
ARA
US0292271055
Healthcare Facilities & Services
Business description: American Renal Associates Holdings, Inc.

Sales by Activity: American Renal Associates Holdings, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
The Ownership and Operation of Dialysis Clinics | 823M |
Geographical breakdown of sales: American Renal Associates Holdings, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
United States | 823M |
Executive Committee: American Renal Associates Holdings, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
David Doerr
CEO | Chief Executive Officer | 56 | 2025-01-31 |
Syed Kamal
PSD | President | 73 | 1998-12-31 |
George Attmore
DFI | Director of Finance/CFO | - | - |
Geoffrey Walker
CTO | Chief Tech/Sci/R&D Officer | - | - |
Steve Duke
CTO | Chief Tech/Sci/R&D Officer | - | - |
Company details: American Renal Associates Holdings, Inc.
American Renal Associates Holdings, Inc.
500 Cummings Center
01915, Beverly
+978 922 3080
http://www.innovativerenal.com
Other Healthcare Facilities & Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.67% | -4.26% | +30.46% | +38.73% | 119B | ||
| +5.64% | +6.06% | +5.98% | +56.17% | 92.92B | ||
| +1.28% | +4.26% | +35.60% | +84.61% | 26.97B | ||
| +3.00% | +4.80% | +56.42% | +286.31% | 22.61B | ||
| -0.25% | +4.12% | -3.92% | -7.61% | 22.17B | ||
| +1.48% | +1.75% | -9.32% | +14.59% | 14.47B | ||
| -1.83% | -2.19% | -7.94% | -9.00% | 12.42B | ||
| -0.81% | -3.47% | +23.84% | +70.98% | 11.08B | ||
| +2.54% | +4.26% | -4.48% | +35.60% | 10.45B | ||
| Average | +1.15% | +1.70% | +14.07% | +63.38% | 36.9B | |
| Weighted average by Cap. | +1.68% | +1.13% | +19.01% | +59.24% |

















